SCHEMBL651152

SCHEMBL651152

CC(C)(C)C(c1ccccc1)N1C[C@@H]2[C@H]1CCN2C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.39
FKBP1A P62942 4/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
CCR5 P51681 2/20 0.35
DPP4 P27487 5/20 0.34
DPP8 Q6V1X1 1/20 0.34
CYP2D6 P10635 1/20 0.34
HTT P42858 1/20 0.34
CHRM3 P20309 1/20 0.33
AGTR2 P50052 1/20 0.33
DPP7 Q9UHL4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649412 0.77 GPR119 (0.38) KDM4EMEN1KMT2ADPP4CHRM3
SCHEMBL928365 0.75 CHRM2 (0.35) RIPK1MEN1KMT2ADPP4DPP8
SCHEMBL17821462 0.72 KMT2A (0.42) RIPK1KDM4EMEN1KMT2ACYP2D6
SCHEMBL28429419 0.70 KMT2A (0.40) RIPK1FKBP1AMEN1KMT2AHTT
SCHEMBL3494682 0.69 KMT2A (0.39) MEN1KMT2ACHRM3
SCHEMBL17781830 0.68 KMT2A (0.41) FKBP1AMEN1KMT2ADPP4CHRM3
SCHEMBL2014668 0.68 KMT2A (0.39) MEN1KMT2A
SCHEMBL4899270 0.68 KMT2A (0.56) KDM4EMEN1KMT2ACYP2D6
SCHEMBL2017923 0.68 KMT2A (0.38) MEN1KMT2ACCR5CYP2D6
SCHEMBL2014085 0.68 KMT2A (0.38) FKBP1AKDM4EMEN1KMT2ACCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed